Reklaim : Corporate Presentation

Disclaimer

The information contained in this presentation (this "Presentation") is provided solely for reads' general knowledge and is provided "as is". Killi Ltd. ("Killi", "Reklaim" or the "Company) makes no representation or warranty, express or implied, as to the

accuracy or completeness of the information contained in this presentation or any other information (whether communicated in written or oral form) regarding the Company or its affiliates transmitted or made available to you. The Company expressly

disclaims any and all liability relating to, or resulting from, the use of this presentation or such other information which may be provided to you.

This Presentation does not constitute an offer to sell, or a solicitation of an offer to buy, any securities of, or to engage in any other transaction with, the Company or any other person. It is provided solely for use by prospective investors in considering

their interest.

None of the Company's securities have been registered with or approved or disapproved by the U.S. Securities and Exchange Commission or by any state or foreign securities commission nor has the U.S. Securities and Exchange Commission or any

state or foreign securities commission reviewed or passed upon the accuracy or adequacy of this presentation. No independent person has confirmed the accuracy or truthfulness of the information contained in this presentation, nor whether it is

complete. Any representation to the contrary is illegal.

Any securities being offered have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws. Any securities offered will be offered to "accredited investors", as

such term is defined under Regulation D and Regulation S under the U.S. Securities Act, respectively, including to persons in Canada who are "accredited investors" as defined under National Instrument 45-106 - Prospectus Exemptions.

The information in this Presentation is not targeted at the residents of any particular country or jurisdiction and is not intended for distribution to, or use by, any person in any jurisdiction or country where such distribution or use would be contrary to

local law or regulation.

All dollar amounts referenced herein, unless otherwise indicated, are expressed in US dollars.

Forward-Looking and Other Cautionary Statements

This Presentation may contain "forward-looking statements" within the meaning of applicable securities laws, including, but not limited to, the Company's strategic plans for the rest of 2021 and into 2022. Forward-looking statements may generally be

identified by the use of the words "anticipates," "projects," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are

based upon the current expectations and beliefs of management. They are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and

uncertainties include, but are not limited to: the uncertainty surrounding the spread of COVID-19 and the impact it will have on the Company's operations and economic activity in general, account vs. user risk; and the risks and uncertainties discussed

in our most recent annual and quarterly reports filed with the Canadian securities regulators and available on the Company's profile on SEDAR at www.sedar.com, which risks and uncertainties are incorporated herein by reference.

TSXV: MyID / OTC: MyIDF 2